Unravelling mechanisms of resistance to CDK4/6 inhibitors using triple negative breast cancer (TNBC)

被引：0
|
作者：
Asghar, U. [1 ]
Barr, A. [2 ]
Cutts, R. [1 ]
Beaney, M. [1 ]
Sampath, D. [3 ]
Giltnane, J. [3 ]
Lacap, J. Arca [3 ]
Herrera-Abreu, M. [1 ]
Bakal, C. [2 ]
Turner, N. [1 ]
机构：
[1] Inst Canc Res, Breast Canc Now, London, England
[2] ICR, Canc Biol, London, England
[3] Genentech Inc, Translat Oncol, San Francisco, CA USA
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
10.1093/annonc/mdx145
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
44P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] IMMUNOLOGICAL MECHANISMS OF RESISTANCE TO CDK4/CDK6 INHIBITORS IN BREAST CANCER
    Petroni, Giulia
    Gouin, Kenneth
    Martinez, Aitziber Buque
    Knott, Simon
    Formenti, Silvia
    Galluzzi, Lorenzo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A763 - A763
  • [2] Identification of subtypes of triple negative breast cancer (TNBC) that are sensitive to CDK4/6 inhibition.
    Asghar, Uzma
    Herrera-Abreu, Maria Teresa
    Cutts, Ros
    Babina, Irina
    Pearson, Alex
    Turner, Nicholas C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] CDK4/6 inhibitors: A potential therapeutic approach for triple negative breast cancer
    Saleh, Lubaid
    Wilson, Caroline
    Holen, Ingunn
    MEDCOMM, 2021, 2 (04): : 514 - 530
  • [4] CDK4/6 inhibitors in breast cancer: a role in triple-negative disease?
    Goel, Shom
    Tolaney, Sara M.
    LANCET ONCOLOGY, 2019, 20 (11): : 1479 - 1481
  • [5] Potential Prospect of CDK4/6 Inhibitors in Triple-Negative Breast Cancer
    Hu, Ye
    Gao, Jiyue
    Wang, Meiling
    Li, Man
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 5223 - 5237
  • [6] Combination of CDK4/6 inhibitors with biguanides for treatment of triple negative breast cancer
    Martinez, Mario Morales
    Gonzalez, Eduardo Mauricio
    Deng, Gang
    Ma, Gaoyuan
    Kim, Hyunsoo
    Stiles, Linsey
    Hamilton, Nalo
    Jung, Michael E.
    Pietras, Richard J.
    Marquez-Garban, Diana C.
    CANCER RESEARCH, 2024, 84 (06)
  • [7] Clinical considerations of CDK4/6 inhibitors in triple-negative breast cancer
    Wang, Runtian
    Xu, Kun
    Gao, Fangyan
    Huang, Jinyi
    Guan, Xiaoxiang
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (02):
  • [8] Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
    Pandey, Kamal
    An, Hee-Jung
    Kim, Seung Ki
    Lee, Seung Ah
    Kim, Sewha
    Lim, Sun Min
    Kim, Gun Min
    Sohn, Joohyuk
    Moon, Yong Wha
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (05) : 1179 - 1188
  • [9] Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of Response
    Guarducci, Cristina
    Bonechi, Martina
    Boccalini, Giulia
    Benelli, Matteo
    Risi, Emanuela
    Di Leo, Angelo
    Malorni, Luca
    Migliaccio, Ilenia
    BREAST CARE, 2017, 12 (05) : 304 - 308
  • [10] CDK4/6 inhibitors: mechanisms of resistance and potential biomarkers of responsiveness in breast cancer
    Cetin, Bulent
    Wabl, Chiara A.
    Gumusay, Ozge
    FUTURE ONCOLOGY, 2022, 18 (09) : 1143 - 1157
12345